Laparoscopic Repair of Cesarean Scar Niche
Laparoscopic Repair Of Cesarean Scar Niche: Randomized Controlled Trial.
1 other identifier
interventional
30
0 countries
N/A
Brief Summary
Evaluation of laparoscopy repair of cesarean scar niche in resolution of symptoms related to niche as compared to expectant management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Mar 2020
Shorter than P25 for phase_2
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 21, 2020
CompletedFirst Posted
Study publicly available on registry
March 13, 2020
CompletedStudy Start
First participant enrolled
March 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2021
CompletedMarch 13, 2020
March 1, 2020
1 year
February 21, 2020
March 11, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
post-menstrual spotting
number of days of post-menstrual spotting "spotting or bleeding after 8 days of menstruation whatever the amount
6 month after intervention
Secondary Outcomes (2)
menstrual related pain
6 month after intervention
infertility
6 month after intervention
Study Arms (2)
laparoscopic repair
EXPERIMENTALsuture repair of cesarean scar niche using laparoscopy
medical treatment
ACTIVE COMPARATORconservative management
Interventions
patient will receive for three months daily without interruption, no pill-free interval drug names is "Genera" BAYERhealthcare
Eligibility Criteria
You may qualify if:
- History of cesarean section.
- Postmenstrual and/or intermenstrual spotting.
- Cesarean scar niche of at least 2 mm in depth diagnosed by saline infusion sonography
You may not qualify if:
- pregnancy
- Uterine anomalies
- Hysterotomy.
- history Placenta previa and MAP
- Upper segment incision, Vertical uterine incision
- submucosal fibroids
- adenomyosis.
- History atypical endometrial cells, cervical dysplasia,
- cervical or pelvic infection.
- Irregular cycle.
- lactation amenorrhea.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- computer-generated sequence
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Specialist & Assistant Lecturer of obstetrics and gynecology
Study Record Dates
First Submitted
February 21, 2020
First Posted
March 13, 2020
Study Start
March 15, 2020
Primary Completion
March 15, 2021
Study Completion
March 30, 2021
Last Updated
March 13, 2020
Record last verified: 2020-03
Data Sharing
- IPD Sharing
- Will not share